Study highlights long-term survival & side effect issues of adjuvant breast cancer therapy


New data published in the Journal of Clinical Oncology show ELLENCE® (epirubicin hydrochloride injection) based chemotherapy regimen has survival benefits with low risk of adverse cardiac events

Source: Eurekalert & others

Last reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
    Published on All rights reserved.



He who has never failed somewhere, that man can not be great.
~ Herman Melville